180 related articles for article (PubMed ID: 894031)
1. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS.
Ralph P; Nakoinz I
J Immunol; 1977 Sep; 119(3):950-54. PubMed ID: 894031
[TBL] [Abstract][Full Text] [Related]
2. Immunologic functions and in vitro activation of cultured macrophage tumor lines.
Ralph P; Nakoinz I; Broxmeyer HE; Schrader S
Natl Cancer Inst Monogr; 1978 May; (48):303-10. PubMed ID: 107454
[TBL] [Abstract][Full Text] [Related]
3. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines.
Ralph P; Nakoinz I
Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroids block newly induced but not constitutive functions of macrophage cell lines: myeloid colony-stimulating activity production, latex phagocytosis, and antibody-dependent lysis of RBC and tumor targets.
Ralph P; Ito M; Broxmeyer HE; Nakoinz I
J Immunol; 1978 Jul; 121(1):300-3. PubMed ID: 670703
[TBL] [Abstract][Full Text] [Related]
5. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent cell-mediated cytotoxicity. Comparative ability of murine Peyer's patch and spleen cells to lyse lipopolysaccharide-coated and uncoated erythrocytes.
Kagnoff MF; Campbell S
Gastroenterology; 1976 Mar; 70(3):341-6. PubMed ID: 1082425
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of murine macrophage-mediated tumor cytotoxicity induced by interferons.
Koestler TP; Johnson WJ; Rieman D; Dalton BJ; Greig RG; Poste G
Cancer Res; 1987 Jun; 47(11):2804-8. PubMed ID: 2436758
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
Leu RW; Leu NR; Shannon BJ; Fast DJ
J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity.
Gardner CR; Wasserman AJ; Laskin DL
Cancer Res; 1987 Dec; 47(24 Pt 1):6686-91. PubMed ID: 3119198
[TBL] [Abstract][Full Text] [Related]
10. All classes of murine IgG antibody mediate macrophage phagocytosis and lysis of erythrocytes.
Ralph P; Nakoinz I; Diamond B; Yelton D
J Immunol; 1980 Nov; 125(5):1885-8. PubMed ID: 7430616
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of C1q biosynthesis suppress activation of murine macrophages for both antibody-independent and antibody-dependent tumor cytotoxicity.
Leu RW; Zhou AQ; Shannon BJ; Herriott MJ
J Immunol; 1990 Mar; 144(6):2281-6. PubMed ID: 2107257
[TBL] [Abstract][Full Text] [Related]
12. Role of tumor necrosis factor in macrophage activation and tumoricidal activity.
Mace KF; Ehrke MJ; Hori K; Maccubbin DL; Mihich E
Cancer Res; 1988 Oct; 48(19):5427-32. PubMed ID: 3416299
[TBL] [Abstract][Full Text] [Related]
13. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
LeFor AT; Eisenthal A; Rosenberg SA
J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
[TBL] [Abstract][Full Text] [Related]
15. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
16. Antibody-dependent cellular cytotoxicity against tumor cells. I. Cultivated bone marrow-derived macrophages kill tumor targets.
Lohmann-Matthes ML; Domzig W; Taskov H
Eur J Immunol; 1979 Apr; 9(4):261-6. PubMed ID: 467489
[TBL] [Abstract][Full Text] [Related]
17. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
[TBL] [Abstract][Full Text] [Related]
18. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
Richter M; Banerjee D; Sklar S
Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
[TBL] [Abstract][Full Text] [Related]
19. T lymphocyte-mediated cytolysis. II. Role of target cell histocompatibility antigens in recognition and lysis.
Berke G; McVey E; Hu V; Clark WR
J Immunol; 1981 Aug; 127(2):782-7. PubMed ID: 6265557
[TBL] [Abstract][Full Text] [Related]
20. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
